Tom Gadek
Director/Board Member chez The University of Colorado
Profil
Thomas R.
Gadek was the founder of SARcode Bioscience, Inc. (founded in 2006) where he held the title of Chief Executive Officer & Director from 2006 to 2013.
He is currently working as a Director at Shire Orphan Therapies GmbH and The University of Colorado.
In his former positions, he served as the Chief Executive Officer & Director at TearSolutions, Inc. from 2016 to 2020, Chief Executive & Scientific Officer, Director at Rogne Bioscience, Inc. from 2010 to 2015, and as an Independent Director at Nevis Brands, Inc. He also worked as a Principal at Genentech, Inc. Dr. Gadek obtained a graduate degree from the Massachusetts Institute of Technology, a doctorate degree from the University of California, Berkeley, and an undergraduate degree from the University of Colorado.
Postes actifs de Tom Gadek
| Sociétés | Poste | Début |
|---|---|---|
| The University of Colorado | Director/Board Member | - |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Director/Board Member | 25/04/2011 |
Anciens postes connus de Tom Gadek
| Sociétés | Poste | Fin |
|---|---|---|
TearSolutions, Inc.
 TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Chief Executive Officer | 01/01/2020 |
Rogne Bioscience, Inc.
 Rogne Bioscience, Inc. BiotechnologyHealth Technology Rogne Bioscience, Inc. is an American company that focuses on researching and developing biotechnology products. The private company is based in Portola Valley. | Chief Executive Officer | 01/01/2015 |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Founder | 01/01/2013 |
| NEVIS BRANDS INC. | Director/Board Member | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Tom Gadek
| Massachusetts Institute of Technology | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
| The University of Colorado | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEVIS BRANDS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
SARcode Bioscience, Inc.
SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Health Technology |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Health Technology |
Rogne Bioscience, Inc.
Rogne Bioscience, Inc. BiotechnologyHealth Technology Rogne Bioscience, Inc. is an American company that focuses on researching and developing biotechnology products. The private company is based in Portola Valley. | Health Technology |
